We are pleased to announce that the Pacific Northwest GI and Liver Update will be held on Friday, September 15 – Saturday, September 16, 2023 in Seattle, WA.
 
The 2023 Pacific Northwest GI and Liver Conference will deliver focused educational updates highlighting clinically relevant advances in the management of patients with chronic liver disease (CLD) and gastrointestinal (GI) disorders. The conference will feature an interactive format to enhance educational impact. Renowned hepatologists and gastroenterologists will lead the development of educational content and serve as program faculty. The faculty will review state-of-the-art developments in GI disorders and CLD.

The forum will deliver emerging science and incorporate expert opinions on best practices for the diagnosis and management of patients with CLD and GI disorders.

​

​

Sincerely,​

​

Pacific Northwest GI & Liver Update Course Directors

Kris Kowdley, MD, AGAF, FAASLD, FACP, FACG
V. Raman Muthusamy, MD, MAS

Scott D. Lee, MD

​

​

Target Audience

This activity has been designed to meet the educational needs of physicians, physician assistants, and nurse practitioners involved in the care of patients with gastrointestinal (GI) disorders and chronic liver disease (CLD).

 

Statement of Need

The goal of this program is to provide important clinical and scientific data on the management of GI disorders and CLD.

​

Learning Objectives

Upon completion of this symposium, participants should be better able to:

• Describe current guidelines for the diagnosis and management of CLD and GI disorders

• Employ an evidence-based approach to the management of CLD and GI disorders

• Identify new advances presented at major congresses and assess their potential impact on clinical practice

 

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati College of Medicine and Focus Medical Communications. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

​

The University of Cincinnati designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

​

Disclosure Statement

All faculty and staff involved in the planning or presentation of continuing education activities provided by the University of Cincinnati are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.

 

All additional planning committee members, the University of Cincinnati College of Medicine, and Focus Medical Communications staff have no relationships to disclose.

 

Learner Assurance Statement

The University of Cincinnati is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s). The University of Cincinnati is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

 

Disclaimer Statement

The opinions expressed during the live activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees’ professional development.